APA (7th ed.) Citation

FH, J., YH, Q., XC, G., HH, L., JC, H., ZH, X., . . . L, W. (2025). Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer. Biomarker research, 13(1), 109. https://doi.org/10.1186/s40364-025-00822-x

Chicago Style (17th ed.) Citation

FH, Ji, et al. "Targeting RPS6KC1 to Overcome Enzalutamide Resistance in Prostate Cancer." Biomarker Research 13, no. 1 (2025): 109. https://doi.org/10.1186/s40364-025-00822-x.

MLA (9th ed.) Citation

FH, Ji, et al. "Targeting RPS6KC1 to Overcome Enzalutamide Resistance in Prostate Cancer." Biomarker Research, vol. 13, no. 1, 2025, p. 109, https://doi.org/10.1186/s40364-025-00822-x.